Stéphanie Guidez
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 22
- CAR-T cell therapy research 9
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 3
- Hematology 22
- Multiple Myeloma Research and Treatments 18
- Co-authors
- Xavier Leleu (24 shared papers)Charles Herbaux (20 shared papers)Guillemette Fouquet (14 shared papers)Thierry Façon (7 shared papers)Cécile Tomowiak (9 shared papers)Vincent Ribrag (3 shared papers)Hélène Demarquette (10 shared papers)Clémentine Sarkozy (5 shared papers)
- Journals
- Blood (9 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)Blood Advances (3 papers)Cancer (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Stéphanie Guidez
39 papers receiving 384 citations
Peers
Comparison fields: 5 of 45
- Hematology 170
- Genetics 134
- Pathology and Forensic Medicine 172
- Oncology 155
- Cancer Research 60
Countries citing papers authored by Stéphanie Guidez
This map shows the geographic impact of Stéphanie Guidez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Guidez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Guidez more than expected).
Fields of papers citing papers by Stéphanie Guidez
This network shows the impact of papers produced by Stéphanie Guidez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Guidez. The network helps show where Stéphanie Guidez may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphanie Guidez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 70 | |
| 2 | 2017 | 62 | |
| 3 | 2014 | 42 | |
| 4 | 2014 | 25 | |
| 5 | 2020 | 24 | |
| 6 | 2013 | 23 | |
| 7 | 2014 | 22 | |
| 8 | 2017 | 15 | |
| 9 | 2020 | 13 | |
| 10 | 2016 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2017 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2014 | 4 | |
| 18 | 2018 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 3 |
About Stéphanie Guidez
Stéphanie Guidez is a scholar working on Oncology, Hematology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 45 papers that have together received 387 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (16 papers), Protein Degradation and Inhibitors (10 papers), CAR-T cell therapy research (9 papers), Peptidase Inhibition and Analysis (7 papers), Cancer Treatment and Pharmacology (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (170 citations), Genetics (134 citations), Pathology and Forensic Medicine (172 citations), Oncology (155 citations) and Cancer Research (60 citations). Stéphanie Guidez has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Xavier Leleu, Charles Herbaux, Guillemette Fouquet, Thierry Façon, Cécile Tomowiak, Vincent Ribrag, Hélène Demarquette, Clémentine Sarkozy, Loïc Renaud and Marie‐Hélène Delfau‐Larue. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Blood Advances and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.